HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nasal Obstruction

Any hindrance to the passage of air into and out of the nose. The obstruction may be unilateral or bilateral, and may involve any part of the NASAL CAVITY.
Also Known As:
Bilateral Nasal Obstruction; Nasal Airway Obstruction; Nasal Blockage; Unilateral Nasal Obstruction; Airway Obstruction, Nasal; Blockage, Nasal; Blockages, Nasal; Nasal Blockages; Nasal Obstruction, Bilateral; Nasal Obstruction, Unilateral; Obstruction, Bilateral Nasal; Obstruction, Nasal; Obstruction, Nasal Airway; Obstructions, Nasal
Networked: 1512 relevant articles (227 outcomes, 198 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Sneezing
2. Rhinorrhea
3. Allergic Rhinitis
4. Pruritus (Itching)
5. Hypertrophy

Experts

1. Nabe, Takeshi: 16 articles (11/2015 - 03/2002)
2. Rhee, John S: 15 articles (02/2022 - 07/2008)
3. Most, Sam P: 15 articles (01/2021 - 09/2006)
4. Mizutani, Nobuaki: 15 articles (11/2015 - 03/2002)
5. Kohno, Shigekatsu: 15 articles (03/2012 - 03/2002)
6. Garcia, Guilherme J M: 14 articles (02/2022 - 05/2012)
7. Kimbell, Julia S: 9 articles (04/2020 - 05/2012)
8. Himi, Tetsuo: 9 articles (04/2017 - 08/2005)
9. Kanaizumi, Etsuko: 9 articles (04/2017 - 08/2005)
10. Shirasaki, Hideaki: 9 articles (04/2017 - 08/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Nasal Obstruction:
1. Adrenal Cortex Hormones (Corticosteroids)IBA
2. Budesonide (Pulmicort)FDA LinkGeneric
3. SteroidsIBA
4. Histamine Antagonists (Antihistamines)IBA
5. Mometasone Furoate (Nasonex)FDA LinkGeneric
6. Nasal Decongestants (Decongestants)IBA
7. desloratadine (Aerius)FDA LinkGeneric
8. Nasal SpraysIBA
9. Histamine (Histamine Dihydrochloride)FDA Link
10. Beclomethasone (Beclometasone)FDA Link
07/16/2008 - "In contrast, one randomised, parallel-group trial did not find significant improvement in nasal obstruction symptoms and adenoid size after eight weeks of treatment with beclomethasone (200 micrograms/day). "
07/16/2008 - "The first eight-week cross-over study showed that treatment with beclomethasone (336 micrograms/day) yielded a greater improvement in mean symptom scores than placebo (-18.5 vs. -8.5, P < 0.05) and a larger reduction in mean adenoid/choana ratio than placebo (right, -14% vs. +0.4%, p=0.002; left, -15% vs. -2.0%, p=0.0006) between week 0 and week 4. The second four-week cross-over study demonstrated that the nasal obstruction index decreased by at least 50% from baseline in 38% of patients treated with beclomethasone (400 micrograms/day) between week 0 and week 2, whereas none of the patients treated with placebo had such improvement (p<0.01). "
03/01/1977 - "A double-blind cross-over study of the effect of insufflation of beclomethasone dipropionate 400 microgram per day for four weeks showed favourable results, as verified statistically, concerning nasal blockage at the end of the treatment period. "
04/01/2021 - "Patients in Group 1 received intranasal beclomethasone dipropionate for two weeks and patients in Group 2 had rhinophototherapy added to the same medical therapy as Group 1. The effectiveness of treatments was evaluated with the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), Nasal Obstruction Symptom Evaluation scale (NOSE) questionnaires and active anterior rhinomanometry. "
07/01/2007 - " interview after the endoscopy revealed that the patient, a 69-year-old female was diagnosed as chronic perennial allergic rhinitis a few years ago, and had been inhaling rhinenchysis Beclometasone dipropionate (BDP) before sleep every day for the past two years because using this collunarium seemed to mitigate the nasal obstruction and mucus during sleep. "

Therapies and Procedures

1. Rhinoplasty
2. Therapeutics
3. Aftercare (After-Treatment)
4. Nasal Surgical Procedures
5. Adenoidectomy